Abstract
Background
Significant myocardial scar in the posterolateral left ventricle (LV) has been associated with a diminished response to cardiac resynchronization therapy (CRT) in patients with coronary artery disease, but the effects of resting perfusion abnormalities in nonischemic cardiomyopathy (NICM) are yet to be described.
Hypothesis
We sought to characterize the effect of myocardial perfusion abnormalities upon echocardiographic outcomes of CRT in patients with NICM.
Methods
Twenty‐one patients (mean age 64.4 ± 13.3; 71.4% male; mean left ventricular ejection fraction [LVEF] 20.2 ± 6.9%) with NICM who underwent CRT implantation and Thallium‐201 single positron emission computed tomography (SPECT) myocardial perfusion imaging (MPI) were included. MPI studies were read quantitatively, assigning each of 17 myocardial segments a perfusion score (0–4) and cumulatively generating a summed perfusion score (SPS). The LV lead position was determined by chest radiography. Echocardiograms were performed both before and after (median 12 mo) CRT in 15 patients.
Results
Echocardiographic response, defined as ≥ 15% relative increase in LVEF, was documented in 8 (53.3%) of 15 patients. All patients (5/5) with an SP ⩽6 responded to CRT, whereas only 30.0% (3/10) with an SPS ≥ 6 responded (odds ratio 3.33 [95% confidence interval {CI} 1.29‐8.59]; p = 0.01). All nonresponders had inferior perfusion defects. Defect density adjacent to the LV lead tip had little demonstrable effect upon CRT efficacy.
Conclusions
The presence of significant myocardial perfusion defects negatively influences echocardiographic response to CRT in NICM. These findings warrant prospective confirmation and histopathological correlation with explanted hearts. Copyright © 2008 Wiley Periodicals, Inc.
Keywords: cardiac resynchronization therapy, dilated cardiomyopathy, myocardial perfusion imaging, echo‐ cardiography
Full Text
The Full Text of this article is available as a PDF (633.3 KB).
References
- 1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, et al.: Cardiac‐resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New Engl J Med 2004; 350: 2140–2150. [DOI] [PubMed] [Google Scholar]
- 2. Cleland JGF, Daubert J‐C, Erdmann E, Freemantle N, Gras D, et al.: The effect of cardiac resynchronization on morbidity and mortality in heart failure. New Engl J Med 2005; 352: 1539–1549. [DOI] [PubMed] [Google Scholar]
- 3. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, et al.: Cardiac resynchronization in chronic heart failure New Engl J Med 2002; 346: 1845–1853. [DOI] [PubMed] [Google Scholar]
- 4. Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, et al.: Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004; 44: 1834–1840. [DOI] [PubMed] [Google Scholar]
- 5. Bleeker GB, Kaandorp TAM, Lamb HJ, Boersma E, Steendijk P, et al.: Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006; 113: 969–976. [DOI] [PubMed] [Google Scholar]
- 6. Bleeker GB, Schalij MJ, Van der Wall EE, Bax JJ: Postero‐lateral scar tissue resulting in nonresponse to cardiac resynchronization therapy. J Cardiovasc Electr 2006; 12: 1–3. [DOI] [PubMed] [Google Scholar]
- 7. Adelstein E, Saba S. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am Heart J 2007; 153: 105–112. [DOI] [PubMed] [Google Scholar]
- 8. Sciagra R, Giaccardi M, Porciani MC, Colella A, Michelucci A, et al.: Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. J Nucl Med 2004; 45: 164–168. [PubMed] [Google Scholar]
- 9. Wu YW, Yen RF, Chieng PU, Huang PJ: Tl‐201 myocardial SPECT in differentiation of ischemic from nonischemic dilated cardiomyopathy in patients with left ventricular dysfunction. J Nucl Cardiol 2003; 10: 369–374. [DOI] [PubMed] [Google Scholar]
- 10. Watanabe M, Gotoh K, Nagashima K, Uno Y, Noda T, et al.: Relationship between thallium‐201 myocardial SPECT and findings of endomyocardial biopsy specimens in dilated cardiomyopathy. Annals of Nucl Med 2001; 15: 13–19. [DOI] [PubMed] [Google Scholar]
- 11. Molhoek SG, Bax JJ, van Erven L, Bootsma M, Boersma E, et al.: Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy. Am J Cardiol 2004; 93: 860–863. [DOI] [PubMed] [Google Scholar]
- 12. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, et al.: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation 2002; 105: 539–542. [DOI] [PubMed] [Google Scholar]
- 13. Helmcke F, Nanda NC, Hsiung MC, Adey CK, Goyal RG, et al.: Color doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987; 75: 175–183. [DOI] [PubMed] [Google Scholar]
- 14. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, et al.: Recommendations for quantification of the left ventricle by two‐dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two‐Dimensional Echocardiograms. J Am Soc Echocardiog 1989; 2: 358–367. [DOI] [PubMed] [Google Scholar]
- 15. Omori Y, Kajiya T, Shiotani H, Takarada A, Nakashima Y, Yokota Y, Fukuzaki H, Maeda K. T1‐201 single‐photon emission computed tomography for clinical assessment of dilated cardiomyopathy. J Cardiogr 1984; 14: 707–718. [PubMed] [Google Scholar]